72 results match your criteria: "Emergency Department CISSS Montérégie Centre[Affiliation]"

Article Synopsis
  • * Machine learning models were applied to predict confirmed disability progression after two years, achieving a ROC-AUC score of 0.71, indicating moderate accuracy, while historical disability was found to be a stronger predictor than treatment or relapse history.
  • * The research followed strict guidelines and made its coding accessible for others to facilitate future benchmarking in predicting disability progression in MS patients.
View Article and Find Full Text PDF

PSA, an outdated biomarker for prostate cancer: In search of a more specific biomarker, citrate takes the spotlight.

J Steroid Biochem Mol Biol

October 2024

Endocrinology - Nephrology Research Axis, Centre de recherche du CHU de Québec - Université Laval, Québec City, Canada; Department of Molecular Medicine, Faculty of Medicine, Université Laval, Québec City, Canada; Centre de recherche sur le cancer de l'Université Laval, Québec City, Canada. Electronic address:

The prevailing biomarker employed for prostate cancer (PCa) screening and diagnosis is the prostate-specific antigen (PSA). Despite excellent sensitivity, PSA lacks specificity, leading to false positives, unnecessary biopsies and overdiagnosis. Consequently, PSA is increasingly less used by clinicians, thus underscoring the imperative for the identification of new biomarkers.

View Article and Find Full Text PDF

Background: The PAROLE-Onco program was introduced in the province of Quebec, Canada in 2019. It integrates accompanying patients (APs), i.e.

View Article and Find Full Text PDF

Rediscovering citrate as a biomarker for prostate cancer.

Nat Rev Urol

October 2024

Endocrinology-Nephrology Research Axis, Centre de recherche du CHU de Québec, Université Laval, Québec City, Québec, Canada.

View Article and Find Full Text PDF

Background: The conventional methods and strategies used for knowledge translation (KT) in academic research often fall short in effectively reaching stakeholders, such as citizens, practitioners, and decision makers, especially concerning complex healthcare issues. In response, a growing number of scholars have been embracing arts-based knowledge translation (ABKT) to target a more diverse audience with varying backgrounds and expectations. Despite the increased interest, utilization, and literature on arts-based knowledge translation over the past three decades, no studies have directly compared traditional knowledge translation with arts-based knowledge translation methods.

View Article and Find Full Text PDF

Integrating accompanying patients into clinical oncology teams: limiting and facilitating factors.

BMC Health Serv Res

January 2024

Institut National d'excellence en Santé Et Services Sociaux (INESSS), Montréal, QC, Canada.

Objectives: Since 2018, four establishments in Quebec have been instrumental in implementing the PAROLE-Onco program, which introduced accompanying patients (APs) into healthcare teams to improve cancer patients' experience. APs are patient advisors who have acquired specific experiential knowledge related to living with cancer, using services, and interacting with healthcare professionals. They are therefore in a unique and reliable position to be able to provide emotional, informational, cognitive and navigational support to patients who are dealing with cancer.

View Article and Find Full Text PDF

The Signature Biobank is a longitudinal repository of biospecimen, psychological, sociodemographic, and diagnostic data that was created in 2012. The Signature Consortium represents a group of approximately one hundred Quebec-based transdisciplinary clinicians and research scientists with various expertise in the field of psychiatry. The objective of the Signature Biobank is to investigate the multi-faceted underpinnings of psychiatric disorders among patients in crisis.

View Article and Find Full Text PDF

Background: In 2016, two Canadian hospitals participated in a quality improvement (QI) program, the International Acute Care for Elders (ACE) Collaborative, and sought to adapt and implement a transition coach intervention (TCI). Both hospitals were challenged to provide optimal continuity of care for an increasing number of older adults. The two hospitals received initial funding, coaching, educational materials, and tools to adapt the TCI to their local contexts, but the QI project teams achieved different results.

View Article and Find Full Text PDF

Lack of association between four biomarkers and persistent post-concussion symptoms after a mild traumatic brain injury.

J Clin Neurosci

December 2023

CHU de Québec-Université Laval Research Centre, 1401, 18e rue, Québec, Québec G1J 1Z4, Canada; Faculté de médecine, Université Laval, 1050 Av. de la Médecine, Québec, Québec G1V 0A6, Canada; VITAM-Centre de recherche en santé durable, 2480 Chem. de la Canardière, Québec, Québec G1J 2G1, Canada. Electronic address:

Approximately 15 % of individuals who sustained a mild Traumatic Brain Injury (TBI) develop persistent post-concussion symptoms (PPCS). We hypothesized that blood biomarkers drawn in the Emergency Department (ED) could help predict PPCS. The main objective of this project was to measure the association between four biomarkers and PPCS at 90 days post mild TBI.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates geographical differences in the risk of secondary progressive multiple sclerosis (SPMS) and how these may be influenced by factors like latitude and treatment types.
  • It utilizes data from a global patient registry, focusing on relapsing-remitting multiple sclerosis patients and factors such as age, sex, and treatment efficacy.
  • The research analyzes data from over 51,000 patients across 27 countries to establish patterns in the progression from relapsing-remitting to secondary progressive phases of the disease.
View Article and Find Full Text PDF

Objectives: Older adults represent more than 50% of trauma admissions in many high-income countries. Furthermore, they are at increased risk for complications, resulting in worse health outcomes than younger adults and a significant health care utilization burden. Quality indicators (QIs) are used to assess the quality of care in trauma systems, but few QIs reflect responses to older patients' specific needs.

View Article and Find Full Text PDF

Background: Centre hospitalier de l'Université de Montréal in Canada introduced accompanying patients (APs) into the breast cancer care trajectory. APs are patients who have been treated for breast cancer and have been integrated into the clinical team to expand the services offered to people affected by cancer. This study describes the profiles of the people who received the support and explores whether one-offs vs ongoing encounters with APs influence their experience of care, on self-efficacy in coping with cancer, and on their level of psychological distress.

View Article and Find Full Text PDF

Introduction: Approximately 33% of people who contracted COVID-19 still experience symptoms 12 weeks after infection onset. This persistence of symptoms is now considered a syndrome itself called 'long COVID'. Evidence regarding long COVID and its cognitive and physical impacts is growing, but the literature is currently lacking objectively measured data to guide towards adapted healthcare trajectories.

View Article and Find Full Text PDF

Introduction: Attachment to a primary care provider is an important component of primary care as it facilitates access. In Québec, Canada, attachment to a family physician is a concern. To address unattached patients' barriers to accessing primary care, the Ministry of Health and Social Services mandated Québec's 18 administrative regions to implement single points of access for unattached patients ( (GAPs)) that aim to better orient patients towards the most appropriate services to meet their needs.

View Article and Find Full Text PDF

Comparative effectiveness in multiple sclerosis: A methodological comparison.

Mult Scler

March 2023

CORe, Department of Medicine, University of Melbourne, Melbourne, VIC, Australia/Neuroimmunology Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia.

Background: In the absence of evidence from randomised controlled trials, observational data can be used to emulate clinical trials and guide clinical decisions. Observational studies are, however, susceptible to confounding and bias. Among the used techniques to reduce indication bias are propensity score matching and marginal structural models.

View Article and Find Full Text PDF
Article Synopsis
  • Prostate cancer relies on the androgen receptor (AR) for its growth and survival, making AR a key target for treatment; however, most tumors eventually progress to a lethal form known as castration-resistant prostate cancer (CRPC).
  • Despite initial responses to AR-targeting therapies, many resistance mechanisms involve the reactivation of AR rather than true androgen independence, leading to confusion about the definitions and utility of preclinical models.
  • A better understanding of the limitations and benefits of various preclinical models is crucial for effectively translating research findings into clinical applications, especially concerning cancer cell behavior and mechanisms of castration resistance.
View Article and Find Full Text PDF
Article Synopsis
  • Ethylene glycol (EG) can lead to serious health issues like metabolic acidemia, neurotoxicity, and acute kidney injury, and historically treatments have included supportive care, antidotes like ethanol or fomepizole, and extracorporeal treatments (ECTRs) like hemodialysis.
  • Recent systematic reviews analyzed the effectiveness of ECTRs in treating EG toxicity, showing that while EG is generally dialyzable, mortality rates varied based on glycolate concentrations, with lower rates seen in certain patient subgroups.
  • The EXTRIP workgroup provided recommendations for ECTR use alongside supportive care, suggesting it may be beneficial under specific conditions related to EG or glycolate concentrations and severe clinical features, although the quality of
View Article and Find Full Text PDF

Accompanying patients in clinical oncology teams: Reported activities and perceived effects.

Health Expect

April 2023

Institut national d'excellence en santé et services sociaux (INESSS), Montréal, Québec, Canada.

Introduction: Since 2018, four establishments in Quebec, Canada, have decided to implement the PAROLE-Onco programme, which introduced accompanying patients (APs) in healthcare teams to improve the experience of cancer patients. APs are patient advisors who have had a cancer treatment experience and who conduct consultations to complement the service offered by providing emotional, informational and educational support to patients undergoing treatments (e.g.

View Article and Find Full Text PDF

Aim: The purpose of this realist review was to assess what works, for whom and in what context, regarding strategies that influence nurses' behaviour to improve triage quality in emergency departments (ED).

Design: Realist review protocol.

Methods: This protocol follows the PRISMA-P statement and will include any type of study on strategies to improve the triage process in the ED (using recognized and validated triage scales).

View Article and Find Full Text PDF

Characteristics, barriers and facilitators of initiatives to develop interprofessional collaboration in rural and remote primary healthcare facilities: a scoping review.

Rural Remote Health

November 2022

Centre de recherche du CISSS Chaudière-Appalaches, 143 rue Wolfe, Lévis, Québec G6V 3Z1, Canada; Collectif de recherche sur la santé en région (CoRSeR), Université du Québec à Rimouski, 300 Allée des Ursulines, Rimouski, Québec G5L 3A1, Canada; Department of Family Medicine and Emergency Medicine, Faculty of Medicine and and Health Sciences, Université de Sherbrooke, 150 place Charles-Le Moyne, Longueuil, Québec J4K 0A8, Canada; and Department of Health Sciences, Université du Québec à Rimouski, 300 Allée des Ursulines, Rimouski, Québec G5L 3A1, Canada

Article Synopsis
  • The article explores the importance of interprofessional collaboration (IPC) in primary health care (PHC), especially in rural and remote areas, highlighting a lack of research on effective initiatives.
  • A scoping review of 94 articles resulted in 23 relevant studies, finding that while ten focused on implementing IPC initiatives, most discussed the barriers and facilitators to these efforts.
  • Key barriers included limited human resources and unclear roles, while facilitators like team size and community connections showed promise for enhancing IPC in these challenging clinical environments.
View Article and Find Full Text PDF

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.

BMC Med Res Methodol

May 2022

Arènes - UMR 6051, RSMS (Recherche sur les Services et Management en Santé) - U 1309, Univ Rennes, EHESP, CNRS, Inserm, Rennes, France.

Background: Natalizumab and fingolimod are used as high-efficacy treatments in relapsing-remitting multiple sclerosis. Several observational studies comparing these two drugs have shown variable results, using different methods to control treatment indication bias and manage censoring. The objective of this empirical study was to elucidate the impact of methods of causal inference on the results of comparative effectiveness studies.

View Article and Find Full Text PDF
Article Synopsis
  • This study looks at how to predict long-term disability in people with multiple sclerosis (MS) after they show signs of worsening over six months.
  • Researchers checked data from thousands of patients to figure out who is more likely to have lasting problems.
  • They found that things like age, sex, and how MS affects the person can help tell if someone will continue to get worse, which can help doctors in future treatments.
View Article and Find Full Text PDF

The Management of Agitated Toxidromes.

Emerg Med Clin North Am

May 2022

Division of Medical Toxicology, Ronald O. Perelman Department of Emergency Medicine, NYU Grossman School of Medicine, 455 First Avenue Room 123, New York, NY 10016, USA.

Taking care of patients with agitated toxidromes can be challenging. While many will be able to be discharged from the emergency department or transferred to psychiatry following brief and simple interventions others will have life-threatening toxicity. Health care providers must develop an organized approach to the assessment and management of these patients that includes foremost the protection of the patient and staff from physical harm, prompt pharmacologic control to allow rapid assessment for life-threatening abnormalities such as hypoglycemia and hyperthermia and optimal cooling of patients with extreme temperature elevations.

View Article and Find Full Text PDF

Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study.

Neurology

June 2022

From the CORe (M.V., I.D., C.M., P.D.M.P., T.K.), Department of Medicine, University of Melbourne, Australia; Melbourne MS Centre (M.V.), Department of Neurology, Faculty of Medicine, P.J. Safarik University, Kosice, Slovakia; Melbourne MS Centre (P.D.M.P., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia; Department of Neurology and Center of Clinical Neuroscience (D.H., E.K.H.), First Faculty of Medicine, Charles University in Prague and General University Hospital, Czech Republic; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia; Multiple Sclerosis Center (F.P.), University of Catania, Italy; Dokuz Eylul University (S.O.), Konak/Izmir, Turkey; Hospital Universitario Virgen Macarena (G. Izquierdo, S.E.), Sevilla, Spain; Isfahan Neurosciences Research Center (INRC) (V.S.), Isfahan University of Medical Sciences (IUMS), Iran; Department of Neuroscience, Imaging, and Clinical Sciences (M.O.), University G. D'Annunzio, Chieti; IRCCS Istituto Delle Scienze Neurologiche di Bologna (A.L.); Dipartimento di Scienze Biomediche e Neuromotorie (A.L.), Universita di Bologna, Italy; Division of Neurology (R. Alroughani), Department of Medicine, Amiri Hospital, Sharq, Kuwait; CHUM MS Center and Universite de Montreal (A.P., C.L., M.G., P.D.), Quebec, Canada; Medical Faculty (M.T.), Ondokuz Mayis University, Samsun; KTU Medical Faculty Farabi Hospital (C. Boz), Trabzon, Turkey; Neuro Rive-Sud (F.G.), Longueuil, Quebec, Canada; Azienda Ospedaliera Universitaria di Modena (P.S.); Department of Biomedical (D.F.), Metabolic and Neurosciences, University of Modena and Reggio Emilia, Italy; CISSS Chaudière-Appalache (P.G.), Levis, Quebec, Canada; Central Clinical School (H.B.), Monash University; Department of Neurology (H.B., O.S.), The Alfred Hospital; Department of Neurology (K.B., O.S.), Box Hill Hospital, Eastern Health; Monash University (K.B., O.S.), Melbourne, Australia; Nehme and Therese Tohme Multiple Sclerosis Center (B.I.Y.), American University of Beirut Medical Center, Lebanon; Hacettepe University (R.K.), Ankara, Turkey; Zuyderland Medical Centre (O. Gerlach), Department of Neurologie, Dr. H. van der Hoffplein 1, Sittard-Geleen, the Netherlands; School of Medicine and Public Health (J.L.-S.), University Newcastle; Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle, Australia; MS Center (D.M.), Neurology Unit, Garibaldi Hospital, Catania; IRCCS Mondino Foundation (R.B.), Pavia, Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Brussels; Université Catholique de Louvain (V.V.P.), Belgium; Ospedali Riuniti di Salerno (G. Iuliano); UOC Neurologia (E. Cartechini), Azienda Sanitaria Unica Regionale Marche-AV3, Macerata, Italy; Hospital de Sao Joao (M.J.S.), Universidade Fernando Pessoa, Porto, Portugal; Nemocnice Jihlava (R. Ampapa), Jihlava, Czech Republic; Brain and Mind Centre (M.B.), Sydney, Australia; Royal Victoria Hospital (S.E.H.), Belfast, UK; Hospital Germans Trias I Pujol (C.M.R.-T.), Badalona, Spain; Liverpool Hospital (S.H.), Sydney, Australia; Liverpool Hospital and Ingham Institute (S.H.), Australia; Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Kommunehospitalet (T.P.), Aarhus, Denmark; Monash Medical Centre (E.G.B.), Melbourne; Flinders University (M.S.), Adelaide, Australia; University College Dublin and St. Vincent's University Hospital (C. McGuigan), Ireland; University of Queensland (P.A.M.); Royal Brisbane and Women's Hospital (P.A.M.), Australia; Department of Medicine and Surgery (F.G.), University of Parma; Department of Emergency and General Medicine (F.G.), Parma University Hospital, Italy; Hospital Italiano (E. Cristiano), Buenos Aires, Argentina; CSSS Saint-Jérôme (J.P.), Saint-Jerome, Quebec, Canada; Royal Hobart Hospital (B.V.T.), Australia; Hospital de Galdakao-Usansolo (J.L.S.Ã.-M.), Galdakao, Spain; Department of Neurology (G.L.), Ghent University Hospital, Corneel Heymanslaan 10; University Hospital Ghent (L.V.H.), Ghent, Belgium; Westmead Hospital (S.V.), Sydney; Austin Health (R.A.M.), Melbourne, Australia; South East Trust (O. Gray), Belfast, UK; Instituto de Investigación Sanitaria Biodonostia (J.O.), Hospital Universitario Donostia, San Sebastián, Spain; Hospital Fernandez (N.D.), Capital Federal, Argentina; Universidade Metropolitana de Santos (Y.D.F.), Santos, Brazil; and Geelong Hospital (C.S.), Geelong, Australia.

Article Synopsis
  • The study aimed to explore how the latitude of residence and UVB radiation exposure affects the severity of multiple sclerosis (MS) among patients, using data from the MSBase registry.
  • Results indicated that patients living at higher latitudes (above 40°) experienced more severe MS symptoms, while this trend was not observed in those living below this latitude.
  • Additionally, lower UVB exposure during childhood (ages 6 and 18) was linked to faster progression of disability in MS, suggesting the importance of environmental factors in disease severity.
View Article and Find Full Text PDF